allodynia glp 1 Frontiers Benefit-Risk Assessment of GLP-1 Receptor

There is a possibility that future studies will find a link between vision loss and other GLP-1 drugs, such as Zepbound

Additionally, exclusion criteria encompassed exposure to angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers or tetracyclines during the second and third trimesters, presence of malignancies or malignancy-related conditions, multiple pregnancies and duplicate cases

10.1155/2021/6635084 2 AgusA.PlanchaisJ.SokolH

[36], in a real-world cohort treated with GLP-1 RAs including exenatide, observed a mean BW loss of 2.5 kg and a BMI reduction of 0.9 kg/m without a significant change in intrahepatic lipid content, reflecting variability in hepatic responses across populations

Obesity (Silver Spring) 23 , 23192320 (2015)

This page covers how the medications work and what the program involves